INS and type 2 diabetes mellitus: Previous studies carried out on animal models with type 2 diabetes demonstrated that the inhibition of PDE3 by cilostazol revised insulin sensitivity by stimulating the peroxisome proliferator-activated receptor (PPAR) γ transcription and anti-inflammatory effects of cAMP-depends in a db/db mouse model of type 2 diabetes [149].